Loading…
Pharmaceutical Market Access Act of 2003
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
79pct
44d open
vs 5,354 other HR bills in the 108th — cohort avg 50d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2006 · year_end · Medicare/Medicaid
Bills with similar content found using semantic analysis.
Sources: Congress.gov
S. 51, Generic Pharmaceutical Access and Choice for Consumers Act of 2003; sections relating to substitution of generic drugs for innovator products. H. 1, Medicare Prescription Drug and Modernization Act of 2003 and S. 1, Prescription Drug and Medicare Improvement Act of 2003, all sections relating to new prescription drug benefits, drug access and reimportation. H.R. 2427, Pharmaceutical Market Access Act of 2003, relating to reimportation. S. 1992, Defense of Medicare and Real Prescription Drug Benefit Act. Medicare Enhancement for Needed Drugs Act of 2004. Implementation of Medicare law -- P.L. 108-173; all sections related to prescription drugs. Deficit Reduction Act. H.R. 2673, Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act, 2004, sections related to FDA funding.
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2006 · year_end · Medical/Disease Research/Clinical Labs
for innovator products. H. 1, Medicare Prescription Drug and Modernization Act of 2003 and S. 1, Prescription Drug and Medicare Improvement Act of 2003, all sections relating to new prescription drug benefits, drug access and reimportation. H.R. 2427, Pharmaceutical Market Access Act of 2003, relating to reimportation. S. 1992, Defense of Medicare and Real Prescription Drug Benefit Act. Medicare Enhancements for Needed Drugs Act of 2004. Implementation of Medicare law -- P.L. 108-173; all sections related to prescription drugs. H.R. 2673, Agriculture, Rural Development, Food & Drug Administration and Related Agencies Appropriations Act, 2004, sections related to FDA funding. S. 51, Generic Pharmaceutical Access and Choice for Consumers Act of 2003; sections relating to substitution of generic drugs
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2004 · year_end · Medicare/Medicaid
In support of drug importation (H.R. 2427, S. 2328)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2004 · year_end · Pharmacy
1. H.R. 1, S. 1, Medicare Prescription Drug Legislation. 2. H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunosuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator jeffords, Bennett, Leahy, Kennedy bills Prospective Payment system Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,640,102 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contct lens as medical devices S1 Prescription Drug and Medicare Improvement oAct of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical market Access Act of 2003 H.R.2857 Pediatric Research Equity Act of 2003 H.R.1170 Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modernization Act the Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,640,102 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2004 · year_end · Health Issues
S. 306, A bill to prohibit discrimination on the basis of genetic information with respect to health insurance and employment. HR 2596, MSAS Health Savings Acct. HR 660 Assn Health Plans. S 1929, Mental Health Parity Extension. S 486, Sen Paul Wellstone Mental Health Parity Extension S 1450 FSA Rollovers Flexible Sprening Accts HR 3901 HR 4372 HR 4520 (S 1637) S 1974 HR 2427 S 2307 S 2328, S 2493 HR 4759 S 2207 HR 4628 S 1945 HR 4279 HR 4372 HR 4280 HR 5 S 11 S 2061 HR 4281 HR 663/S 720 HR 3722 S 486 HR 853 S 1637 HR 4520 S 2572 HR 4694 HR 1818
Client expense: Not reported · Firm income: Not reported
2004 · mid_year · Pharmacy
H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2004 · mid_year · Pharmacy
1. S. 1113, Improved access to osteoporosis testing act of 2003. 2. H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contct lens as medical devices S1 Prescription Drug and Medicare Improvement oAct of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical market Access Act of 2003 H.R.2857 Pediatric Research Equity Act of 2003 H.R.1170 Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modernization Act the Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,958,138 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunosuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R.1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act S.874/H.R.1736 Sickle Cell Treatment Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator jeffords, Bennett, Leahy, Kennedy bills Prospective Payment system Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,958,138 · Firm income: Not reported
2004 · mid_year · Pharmacy
H.R. 2427, S. 2307, S. 2137, relating to the reimportation of prescription drugs.
Client expense: Not reported · Firm income: $120,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218 Regulation of non corrective contact lens as medical devices S.1 Prescription Drug and Medicare Improvement Act of 2003 H.R.1 Medicare Prescription Drug Modernization Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R 1288/S.1037 Access to Cancer Therapies Act of 2003 S.178 Comprehensive Immunospuppressive Drug Coverage for Transplant patients Act of 2003 S.191/H.R.2223 Immunosuppressive drug Coverage Act of 2003 H.R.588 Medicare Fairness for Organ Transplant Recipients Act of 2003 H.R.2356 Prescription Drug Comparative Effectiveness Act of 2003 S.650/H.R.2857 Pediatric Research Equity Act of 2003 H.R.2769 Save our Seniors Act of 2003 H.R.2427 Pharmaceutical Market Access Act of 2003 H.R. 1170 Child Medication Safety Act of 2003 H.R.2218 Federal Food, Drug, and Cosmetic Act Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy - Senator Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture Appropriation 2001 - Drug Reimportation Agriculture Appropriation 2001 (FDA Funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill)
Client expense: $1,474,129 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
HR2218 Regulation of non corrective contact lens as medical devices S1 Prescription Drug and Medicare Improvement Act of 2003 HR1 Medicare Prescription Drug Modernization Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857 Pedicatric Research Equity Act of 2003 HR1170 Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modernization Act The Bipartisan Medicare prescription Drug Act of 2001 (Sen.Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,474,129 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
2003 · year_end · Health Issues
H.R. 2427, Reimportation of prescription drugs legislation.
Client expense: Not reported · Firm income: $40,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2003 · year_end · Health Issues
H.R. 2427, Reimportation of prescription drugs legislation.
Client expense: Not reported · Firm income: $40,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2003 · year_end · Health Issues
HR 1, S 722 HR 3015, HR 2851, HR 2427
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650/HR2857, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs Breaux/Thomas Medicare Reform Plan Health Insurance Portability and Accessibility Act FDA Modernization Act Medical Records Privacy – Senators Jeffords, Bennett, Leahy, Kennedy Bills Prospective Payment System Gene Therapy Drug Reimportation Medicare Reform Agriculture appropriation 2001 – Drug Reimportation Agriculture appropriation 2001 (FDA funding) Stem Cell Research Pediatric Exclusivity Direct-to-Consumer Advertising The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill)
Client expense: $1,479,577 · Firm income: Not reported
H.R.2218, Regulation of non corrective contact lens as medical devices S.1, Prescription Drug and Medicare Improvement Act of 2003 H.R.1, Medicare Prescription Drug Modernization Act of 2003 H.R.2427, Pharmaceutical Market Access Act of 2003 HR1288/S1037, Access to Cancer Therapies Act of 2003 S178, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act of 2003 S191/HR2223, Immunosuppressive Drug Coverage Act of 2003 HR588, Medicare Fairness for Organ Transplant Recipients Act of 2003 HR2356, Prescription Drug Comparative Effectiveness Act of 2003 S.650, Pediatric Research Equity Act of 2003 HR2769, Save our Seniors Act of 2003 HR2427 Pharmaceutical Market Access Act of 2003 HR2857, Pediatric Research Equity Act of 2003 HR1170, Child Medication Safety Act of 2003 Medicare Prescription Drugs & Modfernization Act The Bipartisan Medicare Prescription Drug Act of 2001 (Sen. Kennedy-Draft Bill) Prospective Payment System Medicare Reform
Client expense: $1,479,577 · Firm income: Not reported
2003 · mid_year · Health Issues
H.R. 2427, Reimportation of prescription drugs legislation.
Client expense: Not reported · Firm income: $60,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2003 · mid_year · Health Issues
S. 1 HR 1 HR2427 S7
Client expense: $450,000 · Firm income: Not reported
| Independent |
| VT |
| Charles Taylor | Republican | NC |
| Chris Van Hollen | Democratic | MD |
| Christopher H. Smith | Republican | NJ |
| Christopher Shays | Republican | CT |
| Collin C. Peterson | Democratic | MN |
| Dan Burton | Republican | IN |
| Dana Rohrabacher | Republican | CA |
| Dennis J. Kucinich | Democratic | OH |
| Denny Rehberg | Republican | MT |
| Douglas Bereuter | Republican | NE |
| Ernest Istook | Republican | OK |
| Gerald Kleczka | Democratic | WI |
| Henry Brown | Republican | SC |
| Jack Kingston | Republican | GA |
| James R. Langevin | Democratic | RI |
| James Ramstad | Republican | MN |
| Jeb Hensarling | Republican | TX |
| Jeff Flake | Republican | AZ |
| Jim DeMint | Republican | SC |
| Jo Ann Emerson | Republican | MO |
| John Abney Culberson | Republican | TX |
| John B. Larson | Democratic | CT |
| John F. Tierney | Democratic | MA |
| John J. Duncan, Jr. | Republican | TN |
| John Shadegg | Republican | AZ |
| John W. Olver | Democratic | MA |
| Jonas Frost | Democratic | TX |
| Joseph Crowley | Democratic | NY |
| Kevin Brady | Republican | TX |
| Maurice D. Hinchey | Democratic | NY |
| Michael K. Simpson | Republican | ID |
| Nick Smith | Republican | MI |
| Patrick J. Toomey | Republican | PA |
| Peter Hoekstra | Republican | MI |
| Rahm Emanuel | Democratic | IL |
| Ron Paul | Republican | TX |
| Rosa L. DeLauro | Democratic | CT |
| Roscoe G. Bartlett | Republican | MD |
| Steve King | Republican | IA |
| Thomas Allen | Democratic | ME |
| Thomas E. Petri | Republican | WI |
| Thomas Osborne | Republican | NE |
| Thomas Tancredo | Republican | CO |
| Trent Franks | Republican | AZ |
| Walter B. Jones | Republican | NC |
| Wayne Gilchrest | Republican | MD |
| William Janklow | Republican | SD |
| Wm. Lacy Clay | Democratic | MO |
| Zach Wamp | Republican | TN |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), Vice President of the U.S., White House Office